Your browser doesn't support javascript.
loading
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.
Khanani, Arshad M; Callanan, David; Dreyer, Richard; Chen, Sanford; Howard, James G; Hopkins, J Jill; Lin, Chin-Yu; Lorenz-Candlin, Meike; Makadia, Sneha; Patel, Shienal; Tam, Tammy; Gune, Shamika.
Afiliación
  • Khanani AM; Sierra Eye Associates and the Reno School of Medicine, University of Nevada, Reno, Nevada. Electronic address: arshad.khanani@gmail.com.
  • Callanan D; Texas Retina Associates, Arlington, Texas.
  • Dreyer R; Retina Northwest, Portland, Oregon, and Baylor University, Waco, Texas.
  • Chen S; Orange County Retina, Santa Ana, California.
  • Howard JG; Retina Associates of Utah and the Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah.
  • Hopkins JJ; Genentech, Inc., South San Francisco, California.
  • Lin CY; Genentech, Inc., South San Francisco, California.
  • Lorenz-Candlin M; Genentech, Inc., South San Francisco, California.
  • Makadia S; Genentech, Inc., South San Francisco, California.
  • Patel S; Genentech, Inc., South San Francisco, California.
  • Tam T; Genentech, Inc., South San Francisco, California.
  • Gune S; Genentech, Inc., South San Francisco, California.
Ophthalmol Retina ; 5(8): 775-787, 2021 08.
Article en En | MEDLINE | ID: mdl-33217618
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Agudeza Visual / Sistemas de Liberación de Medicamentos / Degeneración Macular Húmeda / Ranibizumab Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Ophthalmol Retina Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Agudeza Visual / Sistemas de Liberación de Medicamentos / Degeneración Macular Húmeda / Ranibizumab Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Ophthalmol Retina Año: 2021 Tipo del documento: Article